ITC Conference

It consists in a presentation of the own work given by a Young Researcher and Innovator affiliated in an

Inclusiveness Target Country / Near Neighbour Country for their participation in high-level conferences fully organized

by a third party, i.e. not organized nor co-organized by the COST Action.

ITC Conference: Serve COST Excellence and Inclusiveness Policy;

• Support Young Researchers and Innovators affiliated in a legal entity in an Inclusiveness Target Countries/ Near Neighbour Countries to establish a strong network and increase their visibility in the research community

through sharing their work and to gain knowledge;

• Can contribute to increasing visibility of the Action.

----

Dissemination Conference

It consists in an oral presentation by an Action Participant of the work of the Action in high-

level conferences fully organized by a third party, i.e. not organized nor co-organized by the COST Action.

Dissemination Conference:

• Significantly increase visibility of the Action in the research community, can contribute to increasing visibility of

the presenter;

• Attract additional participants and stakeholders and disseminate Action results to relevant end-users at high

profile conferences in the field on a topic relevant to the Action.

Dissemination Conference benefit to:

• Dissemination Conference Grantee: receives support for attending and delivering an oral presentation of the

Action, their activities, and results at a conference and for developing new contacts and potential future

collaborations;

• COST Action: receives increased visibility and awareness, new contacts with potential stakeholders.

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi